Skip to main content

Advertisement

SpringerLink
Log in

Disease activity indices in psoriatic arthritis: current and evolving concepts

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Psoriatic arthritis (PsA) is a highly heterogenous disease, with many different clinical manifestations inside or outside of the musculoskeletal system and the skin. It is often accompanied by comorbidities like cardiovascular diseases and mental health disorders. Acute phase reactants are not always elevated and specific markers for diagnosis and/or monitor the disease are lacking thus far. These characteristics possibly reflect the difficulty in agreement about a disease activity index for PsA. Many indices have been proposed over the last years, each of them considering different combinations of disease characteristics. We performed a literature search for relevant articles using PubMed and Embase. No data limits were applied. The keywords “Psoriatic arthritis” OR “PsA” AND “disease activity” AND “index” OR “indices” were used. Reference lists of relevant articles were also reviewed. Articles were also identified through searches of the authors’ own files. In this review, we comparatively present the available indices (simple or composite) used for measuring activity in PsA, highlighting their weaknesses, strengths, and disparities. We comment also on the caveats and pitfalls that are encountered in assessment of disease activity, in relation to clinical practice and research. A widely accepted index for measuring disease activity in PsA is lacking. Other parameters, mostly related to patient-reported outcomes and to novel biomarkers might be included in the future, in such indices.

Key points

• Disease activity in PsA is multiparametric and its assessment is challenging due to many different phenotypes.

• Many different indices are currently in use of PsA disease activity assessment.

• Each PsA disease activity index has specific pros and cons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

Not applicable.

Code availability

Not applicable.

References

  1. Ritchlin CT, Colbert RA (2017) Gladman DD Psoriatic arthritis. N Engl J Med 376:957–970. https://doi.org/10.1056/NEJMra1505557

    Article  PubMed  Google Scholar 

  2. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Group CS Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673. https://doi.org/10.1002/art.21972

    Article  PubMed  Google Scholar 

  3. Feld J, Chandran V, Haroon N, Inman R (2018) Gladman D Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol 14:363–371. https://doi.org/10.1038/s41584-018-0006-8

    Article  PubMed  Google Scholar 

  4. Perez-Chada LM (2020) Merola JF Comorbidities associated with psoriatic arthritis: review and update. Clin Immunol 214:108397. https://doi.org/10.1016/j.clim.2020.108397

    Article  CAS  PubMed  Google Scholar 

  5. Fragoulis GE, Evangelatos G, Tentolouris N, Fragkiadaki K, Panopoulos S, Konstantonis G, Iliopoulos A, Chatzidionysiou K, Sfikakis PP (2020) Tektonidou MG Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus. Ther Adv Musculoskelet Dis 12:1759720X20976975. https://doi.org/10.1177/1759720X20976975

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wong PC, Leung YY, Li EK (2012) Tam LS Measuring disease activity in psoriatic arthritis. Int J Rheumatol 2012:839425. https://doi.org/10.1155/2012/839425

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lackner A, Duftner C, Ficjan A, Gretler J, Hermann J, Husic R, Graninger WB (2016) Dejaco C The association of clinical parameters and ultrasound verified inflammation with patients’ and physicians’ global assessments in psoriatic arthritis. Semin Arthritis Rheum 46:183–189. https://doi.org/10.1016/j.semarthrit.2016.05.010

    Article  PubMed  Google Scholar 

  8. Mease PJ (2018) Coates LC Considerations for the definition of remission criteria in psoriatic arthritis. Semin Arthritis Rheum 47:786–796. https://doi.org/10.1016/j.semarthrit.2017.10.021

    Article  PubMed  Google Scholar 

  9. Fragoulis GE, Evangelatos G, Konsta M (2020) Iliopoulos A Anterior chest wall involvement in psoriatic arthritis: a forgotten entity? Rheumatology (Oxford) 59:3113–3114. https://doi.org/10.1093/rheumatology/keaa145

    Article  Google Scholar 

  10. FitzGerald O, Haroon M, Giles JT (2015) Winchester R Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther 17:115. https://doi.org/10.1186/s13075-015-0640-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Mease PJ (2011) Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res (Hoboken) 63(Suppl 11):S64-85. https://doi.org/10.1002/acr.20577

    Article  Google Scholar 

  12. van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewe R (2009) Assessment of SpondyloArthritis international S ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818. https://doi.org/10.1136/ard.2008.100826

    Article  PubMed  Google Scholar 

  13. Brikman S, Furer V, Wollman J, Borok S, Matz H, Polachek A, Elalouf O, Sharabi A, Kaufman I, Paran D (2016) Elkayam O The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study. J Rheumatol 43:1749–1754. https://doi.org/10.3899/jrheum.151491

    Article  PubMed  Google Scholar 

  14. Kane D, Stafford L, Bresnihan B (2003) FitzGerald O A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 42:1460–1468. https://doi.org/10.1093/rheumatology/keg384

    Article  CAS  Google Scholar 

  15. Sharif K, Bridgewood C, Dubash S, McGonagle D (2020) Intestinal and enthesis innate immunity in early axial spondyloarthropathy. Rheumatology (Oxford) 59:iv67–iv78. https://doi.org/10.1093/rheumatology/keaa408

    Article  CAS  Google Scholar 

  16. Healy PJ (2008) Helliwell PS Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 59:686–691. https://doi.org/10.1002/art.23568

    Article  PubMed  Google Scholar 

  17. Fassio A, Matzneller P (2020) Idolazzi L Recent advances in imaging for diagnosis, monitoring, and prognosis of psoriatic arthritis. Front Med (Lausanne) 7:551684. https://doi.org/10.3389/fmed.2020.551684

    Article  Google Scholar 

  18. Brockbank JE, Stein M, Schentag CT (2005) Gladman DD Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 64:188–190. https://doi.org/10.1136/ard.2003.018184

    Article  CAS  PubMed  Google Scholar 

  19. Kaeley GS, Eder L, Aydin SZ, Gutierrez M (2018) Bakewell C Dactylitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum 48:263–273. https://doi.org/10.1016/j.semarthrit.2018.02.002

    Article  PubMed  Google Scholar 

  20. Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F, Northington R, Fuiman J, Bananis E, Boggs R (2013) Alvarez D Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 69:729–735. https://doi.org/10.1016/j.jaad.2013.07.023

    Article  PubMed  Google Scholar 

  21. Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP (2019) Egeberg A prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 80(251–265):e219. https://doi.org/10.1016/j.jaad.2018.06.027

    Article  Google Scholar 

  22. Kerschbaumer A, Smolen JS (2018) Aletaha D Disease activity assessment in patients with psoriatic arthritis. Best Pract Res Clin Rheumatol 32:401–414. https://doi.org/10.1016/j.berh.2018.08.004

    Article  PubMed  Google Scholar 

  23. Langley RG (2004) Ellis CN Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician’s Global Assessment. J Am Acad Dermatol 51:563–569. https://doi.org/10.1016/j.jaad.2004.04.012

    Article  PubMed  Google Scholar 

  24. Ogdie A (2015) Weiss P The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am 41:545–568. https://doi.org/10.1016/j.rdc.2015.07.001

    Article  PubMed  PubMed Central  Google Scholar 

  25. Mease PJ, Liu M, Rebello S, McLean RR, Dube B, Glynn M, Hur P (2020) Ogdie A Association of nail psoriasis with disease activity measures and impact in psoriatic arthritis: data from the corrona psoriatic arthritis/spondyloarthritis registry. J Rheumatol. https://doi.org/10.3899/jrheum.190923

    Article  PubMed  Google Scholar 

  26. Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Ujfalussy I, Scarpa R, Marchesoni A, Taylor WJ, Spadaro A, Fernandez-Sueiro JL, Salvarani C, Kalden JR, Lubrano E, Carneiro S, Desiati F, Flynn JA, D’Angelo S, Vacca A (2011) AW VANK, Catanoso MG, Gruenke M, Peluso R, Parsons WJ, Ferrara N, Contu P, Helliwell PS, Mease PJ, Group GPS Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol 38:898–903. https://doi.org/10.3899/jrheum.100857

    Article  PubMed  Google Scholar 

  27. Cervini C, Leardini G, Mathieu A, Punzi L, Scarpa R (2005) Psoriatic arthritis: epidemiological and clinical aspects in a cohort of 1.306 Italian patients. Reumatismo 57:283–290. https://doi.org/10.4081/reumatismo.2005.283

    Article  CAS  PubMed  Google Scholar 

  28. Haroon M, Gallaghar P, Ahmad M (2020) FitzGerald O Elevated CRP even at the first visit to a rheumatologist is associated with long-term poor outcomes in patients with psoriatic arthritis. Clin Rheumatol 39:2951–2961. https://doi.org/10.1007/s10067-020-05065-9

    Article  PubMed  Google Scholar 

  29. Sokolova MV, Simon D, Nas K, Zaiss MM, Luo Y, Zhao Y, Rech J (2020) Schett G A set of serum markers detecting systemic inflammation in psoriatic skin, entheseal, and joint disease in the absence of C-reactive protein and its link to clinical disease manifestations. Arthritis Res Ther 22:26. https://doi.org/10.1186/s13075-020-2111-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Boyd TA, Eastman PS, Huynh DH, Qureshi F, Sasso EH, Bolce R, Temple J, Hillman J, Boyle DL (2020) Kavanaugh A Correlation of serum protein biomarkers with disease activity in psoriatic arthritis. Expert Rev Clin Immunol 16:335–341. https://doi.org/10.1080/1744666X.2020.1729129

    Article  CAS  PubMed  Google Scholar 

  31. Gudu T (2018) Gossec L Quality of life in psoriatic arthritis. Expert Rev Clin Immunol 14:405–417. https://doi.org/10.1080/1744666X.2018.1468252

    Article  CAS  PubMed  Google Scholar 

  32. Sokoll KB (2001) Helliwell PS Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 28:1842–1846

    CAS  PubMed  Google Scholar 

  33. Desthieux C, Granger B, Balanescu AR, Balint P, Braun J, Canete JD, Heiberg T, Helliwell PS, Kalyoncu U, Kvien TK, Kiltz U, Niedermayer D, Otsa K, Scrivo R, Smolen J, Stamm TA, Veale DJ, de Vlam K, de Wit M (2017) Gossec L Determinants of patient-physician discordance in global assessment in psoriatic arthritis: a multicenter European study. Arthritis Care Res (Hoboken) 69:1606–1611. https://doi.org/10.1002/acr.23172

    Article  Google Scholar 

  34. Soriano ER, Zazzetti F, Alves Pereira I, Maldonado Cocco J, Feijo Azevedo V, Guerra G, Bautista-Molano W, Casasola JC, Vega Morales D, Gil DR, Lobosco S (2020) Lawson F Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America. Clin Rheumatol 39:1859–1869. https://doi.org/10.1007/s10067-019-04870-1

    Article  PubMed  Google Scholar 

  35. Leung YY, Orbai AM, Ogdie A, Coates LC, de Wit M, Callis Duffin K, Eder L, Gladman DD, Goel N, Mease PJ, Strand V, FitzGerald O (2019) Tillett W The GRAPPA-OMERACT psoriatic arthritis working group at the 2018 annual meeting: report and plan for completing the core outcome measurement set. J Rheumatol Suppl 95:33–37. https://doi.org/10.3899/jrheum.190122

    Article  PubMed  Google Scholar 

  36. Hojgaard P, Klokker L, Orbai AM, Holmsted K, Bartels EM, Leung YY, Goel N, de Wit M, Gladman DD, Mease P, Dreyer L, Kristensen LE, FitzGerald O, Tillett W, Gossec L, Helliwell P, Strand V, Ogdie A, Terwee CB (2018) Christensen R A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: a GRAPPA-OMERACT initiative. Semin Arthritis Rheum 47:654–665. https://doi.org/10.1016/j.semarthrit.2017.09.002

    Article  PubMed  Google Scholar 

  37. Orbai AM, Holland R, Leung YY, Tillett W, Goel N, Christensen R, McHugh N, Gossec L, de Wit M, Hojgaard P, Coates LC, Mease PJ, Birt J, Fallon L, FitzGerald O, Ogdie A, Shea B, Strand V, Duffin KC, Tugwell P, Beaton D (2019) Gladman DD PsAID12 provisionally endorsed at OMERACT 2018 as core outcome measure to assess psoriatic arthritis-specific health-related quality of life in clinical trials. J Rheumatol 46:990–995. https://doi.org/10.3899/jrheum.181077

    Article  PubMed  Google Scholar 

  38. Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S (2018) Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Ann Rheum Dis 77:1311–1317. https://doi.org/10.1136/annrheumdis-2017-212076

    Article  PubMed  Google Scholar 

  39. Morante I, Aurrecoechea E, Villa I, Santos M, Riancho L (2021) Queiro R Construct validity of the ASAS health index in psoriatic arthritis: a cross-sectional analysis. Rheumatology (Oxford) 60:1465–1473. https://doi.org/10.1093/rheumatology/keaa626

    Article  Google Scholar 

  40. Smolen JS, Schoels M (2015) Aletaha D Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review. Clin Exp Rheumatol 33:S48-50

    PubMed  Google Scholar 

  41. Mumtaz A, Gallagher P, Kirby B, Waxman R, Coates LC, Veale JD, Helliwell P (2011) FitzGerald O Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 70:272–277. https://doi.org/10.1136/ard.2010.129379

    Article  PubMed  Google Scholar 

  42. Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand V, Waxman R, Azevedo VF, Beltran Ostos A, Carneiro S, Cauli A, Espinoza LR, Flynn JA, Hassan N, Healy P, Kerzberg EM, Lee YJ, Lubrano E, Marchesoni A, Marzo-Ortega H, Porru G, Moreta EG, Nash P, Raffayova H, Ranza R, Raychaudhuri SP, Roussou E, Scarpa R, Song YW, Soriano ER, Tak PP, Ujfalussy I, de Vlam K (2013) Walsh JA The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis 72:986–991. https://doi.org/10.1136/annrheumdis-2012-201341

    Article  PubMed  Google Scholar 

  43. Helliwell PS, FitzGerald O (2014) Fransen J Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response. J Rheumatol 41:1212–1217. https://doi.org/10.3899/jrheum.140172

    Article  PubMed  Google Scholar 

  44. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V et al (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727–735. https://doi.org/10.1002/art.1780380602

    Article  CAS  PubMed  Google Scholar 

  45. Coates LC, Fransen J (2010) Helliwell PS Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 69:48–53. https://doi.org/10.1136/ard.2008.102053

    Article  CAS  PubMed  Google Scholar 

  46. Coates LC, FitzGerald O, Merola JF, Smolen J, van Mens LJJ, Bertheussen H, Boehncke WH, Callis Duffin K, Campbell W, de Wit M, Gladman D, Gottlieb A, James J, Kavanaugh A, Kristensen LE, Kvien TK, Luger T, McHugh N, Mease P, Nash P, Ogdie A, Rosen CF, Strand V, Tillett W, Veale DJ (2018) Helliwell PS Group for research and assessment of psoriasis and psoriatic arthritis/outcome measures in rheumatology consensus-based recommendations and research agenda for use of composite measures and treatment targets in psoriatic arthritis. Arthritis Rheumatol 70:345–355. https://doi.org/10.1002/art.40391

    Article  PubMed  Google Scholar 

  47. Duarte-Garcia A, Leung YY, Coates LC, Beaton D, Christensen R, Craig ET, de Wit M, Eder L, Fallon L, FitzGerald O, Gladman DD, Goel N, Holland R, Lindsay C, Maxwell L, Mease P, Orbai AM, Shea B, Strand V, Veale DJ, Tillett W (2019) Ogdie A Endorsement of the 66/68 joint count for the measurement of musculoskeletal Disease activity: OMERACT 2018 psoriatic arthritis workshop report. J Rheumatol 46:996–1005. https://doi.org/10.3899/jrheum.181089

    Article  PubMed  PubMed Central  Google Scholar 

  48. Wervers K, Luime JJ, Tchetverikov I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael J, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Vis M (2019) for C Comparison of disease activity measures in early psoriatic arthritis in usual care. Rheumatology (Oxford) 58:2251–2259. https://doi.org/10.1093/rheumatology/kez215

    Article  Google Scholar 

  49. Smolen JS, Schols M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewe R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, Vlam K (2018) van der Heijde D Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis 77:3–17. https://doi.org/10.1136/annrheumdis-2017-211734

    Article  PubMed  Google Scholar 

  50. Mandl P, Navarro-Compan V, Terslev L, Aegerter P, van der Heijde D, D’Agostino MA, Baraliakos X, Pedersen SJ, Jurik AG, Naredo E, Schueller-Weidekamm C, Weber U, Wick MC, Bakker PA, Filippucci E, Conaghan PG, Rudwaleit M, Schett G, Sieper J, Tarp S, Marzo-Ortega H, Ostergaard M (2015) European League Against R EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 74:1327–1339. https://doi.org/10.1136/annrheumdis-2014-206971

    Article  CAS  PubMed  Google Scholar 

  51. Mathew AJ, Coates LC, Danda D (2017) Conaghan PG Psoriatic arthritis: lessons from imaging studies and implications for therapy. Expert Rev Clin Immunol 13:133–142. https://doi.org/10.1080/1744666X.2016.1215245

    Article  CAS  PubMed  Google Scholar 

  52. Eder L, Aydin SZ, Kaeley GS, Maksymowych WP (2018) Ostergaard M Options for assessing joints and entheses in psoriatic arthritis by ultrasonography and magnetic resonance imaging: how to move forward. J Rheumatol Suppl 94:44–47. https://doi.org/10.3899/jrheum.180140

    Article  PubMed  Google Scholar 

  53. Maldonado-Ficco H, Sheane BJ, Thavaneswaran A, Chandran V (2017) Gladman DD Magnetic resonance imaging in psoriatic arthritis: a descriptive study of indications, features and effect on treatment change. J Clin Rheumatol 23:243–245. https://doi.org/10.1097/RHU.0000000000000558

    Article  PubMed  Google Scholar 

  54. Palominos PE, Coates L, Kohem CL, Orbai AM, Smolen J, de Wit M, Kiltz U, Leung YY, Canete JD, Scrivo R, Balanescu A, Dernis E, Meisalu S, Soubrier M, Aydin SZ, Gaydukova I, Kalyoncu U (2020) Gossec L Determinants of sleep impairment in psoriatic arthritis: an observational study with 396 patients from 14 countries. Joint Bone Spine 87:449–454. https://doi.org/10.1016/j.jbspin.2020.03.014

    Article  PubMed  Google Scholar 

  55. McGagh D (2020) Coates LC Assessment of the many faces of PsA: single and composite measures in PsA clinical trials. Rheumatology (Oxford) 59:i29–i36. https://doi.org/10.1093/rheumatology/kez305

    Article  Google Scholar 

  56. Ogdie A, de Wit M, Callis Duffin K, Campbell W, Chau J, Coates LC, Eder L, Elmamoun M, FitzGerald O, Gladman DD, Goel N, James J, Kalyoncu U, Latella J, Lindsay C, Mease PJ, O’Sullivan D, Steinkoenig I, Strand V, Tillett W (2017) Orbai AM Defining outcome measures for psoriatic arthritis: a report from the GRAPPA-OMERACT working group. J Rheumatol 44:697–700. https://doi.org/10.3899/jrheum.170150

    Article  PubMed  PubMed Central  Google Scholar 

  57. Chandran V, Abji F, Perruccio AV, Gandhi R, Li S, Cook RJ (2019) Gladman DD Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis. Ann Rheum Dis 78:796–801. https://doi.org/10.1136/annrheumdis-2018-214737

    Article  CAS  PubMed  Google Scholar 

  58. Pouw J, Leijten E, Radstake T (2020) Boes M Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: a review of literature. Clin Immunol 211:108318. https://doi.org/10.1016/j.clim.2019.108318

    Article  CAS  PubMed  Google Scholar 

  59. Su YJ (2020) Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing. Clin Rheumatol 39:3677–3684. https://doi.org/10.1007/s10067-020-05132-1

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Propaedeutic Internal Medicine, Medical School, Rheumatology Unit, “Laiko” General Hospital, National and Kapodistrian University of Athens, Agiou Thoma 17 str, 11527, FirstGoudi, Athens, Greece

    Chrysoula G. Gialouri & George E. Fragoulis

  2. Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, Scotland

    George E. Fragoulis

Authors
  1. Chrysoula G. Gialouri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George E. Fragoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Both authors contributed in the manuscript writing and editing.

Corresponding author

Correspondence to George E. Fragoulis.

Ethics declarations

Ethics approval

Not applicable.

Consent to participate.

Not applicable.

Consent for publication.

Not applicable.

Disclosures

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gialouri, C.G., Fragoulis, G.E. Disease activity indices in psoriatic arthritis: current and evolving concepts. Clin Rheumatol 40, 4427–4435 (2021). https://doi.org/10.1007/s10067-021-05774-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-021-05774-9

Keywords

Search

Navigation